Abstract
The U.S. has faced long-standing shortages of generic drugs, causing negative health effects and spikes in drug costs. To address these shortages, investments in critical technologies and policies to support their adoption will be needed. The success of these technologies and policies depends on public acceptance. We studied public acceptance using the mental model approach, which identifies gaps in understanding that can be addressed with communications. We began with semi-structured interviews with experts in pharmaceutical manufacturing. Based on these interviews, we developed and conducted surveys of the general public, physicians, and pharmacists. Similar strategies could be applied to improve communications for other quality risk management issues, such as the adoption of novel pharmaceutical technologies and regulatory practices.
Recommended Citation
Grayek, Emily and Fischhoff, Baruch
(2023)
"Achieving Warranted Acceptance of Biotechnologies,"
Level 3:
Vol. 19:
Iss.
1, Article 13.
doi:https://doi.org/10.21427/v2cq-hn10
Available at:
https://arrow.tudublin.ie/level3/vol19/iss1/13
DOI
https://doi.org/10.21427/v2cq-hn10
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 4.0 International License.